184.45 USD
↗ 0.07 (0.04%)AT CLOSE (03:59 PM EST)
AstraZeneca PLC
AZNNYSE • USD
188.02
↗ 3.58 (1.94%)
POST MARKET (AS OF 08:13 PM EST)
Post Market
AS OF 08:13 PM EST
188.02
↗ 3.58 (1.94%)
Market: CLOSED
Shares of AstraZeneca PLC (AZN) are trading at $184.45. AZN shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9 and a bearish Death Cross on the long-term moving averages. On the valuation front, AZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 13, 2026.
Open?$184.77
High?$186.15
Low?$183.93
Prev. Close?$184.38
Volume?1.9M
Avg. Volume?3.0M
VWAP?$185.08
Rel. Volume?0.62x
Bid / Ask
Bid?$184.05 × 100
Ask?$192.00 × 200
Spread?$7.95
Midpoint?$188.03
Valuation & Ratios
Market Cap?286.1B
Shares Out?N/A
P/E Ratio?128.80
P/B Ratio?21.14
EPS?$1.43
Dividend?1.24%
Ex-Dividend?N/A
News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Themes
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?98
Momentum?6
Short Sent.?58
Piotroski F-Score?2/9Weak
Altman Z-Score?5.01Safe
Confidence?58%Low
Short InterestLow
Short Interest?3.0M
Days to Cover?1.0
Avg Daily Volume3.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?0.93Weak
Quick Ratio?0.76Weak
Cash Ratio?0.27Low
Debt/Equity?1.40Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?128.8PRICEY▾
Peers25
S&P3
P/B?21.14HIGH▾
Peers22
S&P6
P/S?11.89HIGH▾
Peers27
S&P5
P/FCF?125.7PRICEY▾
Peers13
S&P3
EV/EBITDA?56.5HIGH▾
Peers13
S&P3
EV/Sales?12.52HIGH▾
Peers27
S&P7
Returns & Efficiency
ROE?16.4%STRONG▾
Peers38
S&P58
ROA?3.5%FAIR▾
Peers38
S&P31
Cash Flow & Enterprise
FCF?$2.3B
Enterprise Value?$301.2B
Fundamentals ratios updated end of day